Autonomix Medical (NASDAQ:AMIX) Posts Quarterly Earnings Results, Beats Expectations By $1.38 EPS

Autonomix Medical (NASDAQ:AMIX) released its quarterly earnings results on Wednesday. The company reported ($5.02) earnings per share for the quarter, beating analysts’ consensus estimates of ($6.40) by $1.38, FiscalAI reports.

Autonomix Medical Stock Performance

Shares of AMIX traded down $0.73 during trading hours on Thursday, hitting $6.80. The company had a trading volume of 212,932 shares, compared to its average volume of 1,562,243. The stock has a market capitalization of $6.60 million, a price-to-earnings ratio of -0.09 and a beta of -1.17. Autonomix Medical has a 52-week low of $2.44 and a 52-week high of $32.55. The firm has a fifty day moving average price of $6.86 and a 200-day moving average price of $7.76.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Zacks Research raised Autonomix Medical to a “hold” rating in a research note on Tuesday, June 2nd. Weiss Ratings upgraded shares of Autonomix Medical from a “sell (e)” rating to a “sell (e+)” rating in a report on Tuesday, July 28th. One equities research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $42.00.

About Autonomix Medical

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.